Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1055-1063

  Cury, Nathália Moreno ^a   Russo, Anelise ^a   Galbiatti, Ana Ĺivia Silva ^a   Ruiz, Mariângela Torreglosa ^a   Raposo, Luiz Sergio ^a   Maniglia, José Victor ^a   Pavarino, Érika Cristina ^a   Goloni Bertollo, Eny Maria ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

CYP1A1 and CYP2E1 genes; Head and neck squamous cell carcinoma; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; CYP1A1 PROTEIN, HUMAN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; CYP1A1 GENE; CYP2E1 GENE; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; TUMOR GENE; DRINKING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; RISK; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL;

AGE FACTORS; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; LOGISTIC MODELS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SMOKING;

EID: 84860348312     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0831-1     Document Type: Article

References (65)

1. Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillo-mavirus. J Dent Res 86:104
2. Olivieri EHR, da Silva SD, Mendonça FF, Urata YN, Vidal DO, Faria MAM et al (2009) CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol 45(9): 73-79
3. Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194-200
4. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2008) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of HNSCC: pooled analysis in the international HNSCC epidemiology consortium. J Natl Cancer Inst 99(10):777-789, 2007. Erratum in: J Natl Cancer Inst 100(3):225 (Pubitemid 47073524)
5. Hiyama T, Yoshihara M, Tamaka S, Chayama K (2008) Genetic polymorphisms and head and neck cancer risk. Int J Oncol 32: 945-973
6. Zain RB (2007) Cultural and dietary risk factors of oral cancer and precancer-a brief overview. Oral Oncol 37:205-210
7. Guengerich FP (2007) Mechanisms of cytochrome P450 substrate oxidation: minireview. J Biochem Mol Toxicol 21(4):163-168 (Pubitemid 350194375)
8. Abbas A, Delvinquiére K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G et al (2004) GSTM1, GSTT, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility esophageal cancer in French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 23:3389-3393 (Pubitemid 39549534)
9. Evans AJ, Henner WD, Eilers KM, Montalto MA, Wersinger EM, Andersen PE et al (2004) Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck 26:63-70 (Pubitemid 38030151)
10. 0 regulatory RsaI/PstI allelic variants and their role in risk of oral cancer. Oral Oncol 37:437-445 (Pubitemid 32480281)
11. Harth V, Schäfer M, Abel J, Maintz L, Neuhaus T, Besuden M et al (2008) Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair 2. J Toxicol Environ Health 71:887-897 (Pubitemid 352000694)
12. Wunsch A, Ahda Y, Banaz-YaSar F, Sonntag B, Nieschlag E, Simoni M et al (2005) Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 84(2):446-453 (Pubitemid 41125268)
13. Androtsopoulos VP, Tsatsakis AM, Spandidos DA (2009) Cyto-chrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187
14. Rusin P, Marckiewicz L, Majsterek I (2008) Genetic predeterminations of head and neck cancer. Postepy Hig Med Dosw 62: 490-501
15. Božina N, Bradamante V, Lovrić M (2009) Genetic polymorphism of metabolic enzymes P450 (Cyp) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Tok-sikol 60:217-242
16. Gattas GJF, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J et al (2006) Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28:819-826 (Pubitemid 44320536)
17. Liu R, Yin LH, Pu YP (2007) Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Chin Med J 120: 1797-1802 (Pubitemid 350111086)
18. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618-627 (Pubitemid 41768782)
19. Juárez-Cedillo T, Vallejo M, Fragoso JM, Hernández- Hernández DM, Rodŕiguez-Pérez JM, Sánchez- García S et al (2007) The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism. Eur J Cancer 43(10):1590-1595 (Pubitemid 46891804)
20. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112-123 (Pubitemid 40725973)
21. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK et al (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer 89:1207-1212 (Pubitemid 27350030)
22. Lee KJ (2003) Essential otorhinolaryngology. Head Neck Surg 8:1136
23. Liu CJ, Chang CS, Lui MT, Dang CW, Shih YH, Chang KW (2005) Association of GST genotypes whith age of onset and lymph node metatasis in oral squamous cell carcinoma. J Oral Pathol Med 54:475-481
24. a. Edição. Ministério da Saúde. Rio de Janeiro: INCA 2004
25. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC Cancer Staging Manual, 6th ed. New York, Springer
26. Sobin LH, Wittelind CH (2000) Internacional union against cancer: TNM classification of malignant tumours, 6th edn. Wiley, New York
27. Ahrendt SA, Chown JT, Yang SC, Wu L, Zhang M-J, Jen J et al (2000) Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in nomsmall cell lung cancer. Cancer Res 60:3155-3159 (Pubitemid 30407910)
28. Kjaerheim K, Gaard M, Andersen A (1998) The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: a prospective study of 10, 900 Norwegian men. Cancer Causes Control 9(1):99-108 (Pubitemid 28048665)
29. Miller AS, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
30. Arvanitis DA, Goumenou AG, Matalliotaski IM, Koumantaski EE, Spandidos DA (2001) Low penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril 76:1202
31. KatoS, ShieldsPG, CaporasoNE, HooverRN, Trump BF, Sugimura H et al (1992) Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52:6712-6715
32. Hirvonen A, Husgafvel-Pursianen K, Karjalainen A, Antilla S, Vainio H (1993) The human CYP2E1 gene and lung cancer: Dra1 and Rsa1 restriction length polymorphisms in a Finnish study population. Carcinogenesis 14:85-88 (Pubitemid 23152748)
33. Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolar & Head Neck Surg 13:207-211 (Pubitemid 41003846)
34. Marques CFS, Koifman S, Koifman RJ, Boffetta P, Brennan P, Hatagima A (2006) Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 42:632-637 (Pubitemid 44173019)
35. Galbiatti AL, Ruiz MT, Rezende Pinto D, Raposo LS, Maníglia JV, Pavarino-Bertelli EC et al. (2010) A80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squa-mous cell carcinoma etiology in Brazilian population. Mol Biol Rep. dio:10.1007/s11033-010-0204-1
36. Boffeta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149-156 (Pubitemid 43159501)
37. Warnakulasuriya S, Sutherland G, Scully C (2008) Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41:244-260
38. Dedivitis RA, França CM, Mafra ACB, Guimarães FT, Gui-marães AV (2004) Características clí nicoepidemiológicas no carcinoma espinocelular de boca e orofaringe. Ver Bras Otorhi-nolaryngol 70:35-40 (Pubitemid 40137124)
39. 0 s result 1993-2002. J Craniomaxillofac Surg 35:120-125
40. Hershkovich O, Shafat I, Nagler RM (2007) Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J Gerontol A Biol Sci Med Sci 62:361-366 (Pubitemid 47065702)
41. Du D, Shi YH, Le GW (2010) Oxidative stress induced by high-glucose diet in liver of C57BL/6 J mice and its underlying mechanism. Mol Biol Rep 37:3833-3839
42. Gronau S, Koing-Greger D, jerg M, Riechelmann H (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otorhinolaryngol Head Neck Surg 5:674-680 (Pubitemid 41123130)
43. Buch SC, Nazar-Stewart V, Weissfeld JL, Romkers M (2008) Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 30:1139-1147
44. Singh AP, Shah PP, Ruwali M, Mathur N, Pant MC, Parmar D (2009) Related articles polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk. Cancer Invest 27(8):869-876
45. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1999) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131-133
46. Houlston RS (2000) CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10(2):105-114 (Pubitemid 30193072)
47. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D et al (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32:60-63 (Pubitemid 36503475)
48. Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML et al (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104:650-657 (Pubitemid 36337268)
49. Goodman MT, McDuffie K, Hernandez B et al (2001) CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81:263-269 (Pubitemid 32424172)
50. Cha I-H, Park JY, Chung W-Y, Choi M-A, Kim H-J, Park K-k (2007) Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsci Med J 48:233-239 (Pubitemid 46711753)
51. Leichsenring A, Losi-Guembarovski R, Maciel ME, Losi-Gue-mbarovski A, Oliveira BW, Ramos G et al (2006) CYP1A1 and GSTP1 polymorphisms in an oral cancer case-control study. Braz J Med Biol Res 39(12):1569-1574 (Pubitemid 46357842)
52. Bergheim I, Wolfgarten E, Bollschweiler E, Hölscher AH, Bode C, Parlesak A (2007) Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J Gastroenterol 13(7):997-1002 (Pubitemid 46510999)
53. Matthias C, Jahnke V, Jones PW, Hoban PR, Alldersea JE, Worrall SF et al (1999) Cyclin D1, glutathione S-transferase, and cytocrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomakers Prev 8:815-823 (Pubitemid 29445019)
54. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N et al (1999) Genetic polymorphisms of tobacco and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 83:606-609 (Pubitemid 29508037)
55. Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Bröde P et al (2004) Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett 151:273-282 (Pubitemid 38739050)
56. Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, Lauretis A (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93-100 (Pubitemid 350060689)
57. Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM et al (1995) Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Bio-markers Prev 4:607-610
58. Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N et al (2001) Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 1:4
59. Gonzalez MV, Alvarez V, Pello MF, Menendez MJ, Suarez C, Coto E (1998) Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 51:294-298 (Pubitemid 28280999)
60. Gao CM, Takezaki T, Wu JZ, Chen MB, Liu YT, Ding JH et al (2007) CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. World J Gastroenterol 13:5725-5730 (Pubitemid 350120225)
61. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S et al (2006) Gene-environment interaction involved in oral carcinogenesis: molecular epidemio- logical study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 35:11-18
62. Bouchard C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Be-nhamou S (2000) Role of alcohol dehydrogenase 3 and cyto-chrome P-450E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734-740 (Pubitemid 30620418)
63. Agulnik M (2007) Malignancies of head and neck: the role for molecular targeted agents. Expert Opin Ther Targets 11(2):207-217 (Pubitemid 46188814)
64. Stwart BM, Kleihues P (2003) World cancer report. IARC Press, Lyon
65. MatthiasC, BockmuhlU, JahnkeV, Jones PW, Hayes JD, Alldersea J et al (1998) Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodi-gestive tract cancers. Pharmacogenetics 8:91-100 (Pubitemid 28227316)